Tailored treatments for children with sepsis

Personalized Therapies of Pediatric Sepsis

['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11113514

This study is looking at how to better treat children with sepsis by figuring out different types of the condition that might need different treatments, using data from their vital signs in the ICU to find more personalized and effective care for these young patients.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded)
Locations1 site (PITTSBURGH, UNITED STATES)
Trial IDNIH-11113514 on ClinicalTrials.gov

What this research studies

This research focuses on improving treatment for pediatric sepsis by identifying specific subtypes of the condition that may respond differently to various therapies. By analyzing continuously monitored vital sign data from children in intensive care, the study aims to uncover insights into the physiological changes associated with sepsis. This approach seeks to move away from the traditional one-size-fits-all treatment model, potentially leading to more effective and personalized therapies for young patients suffering from this life-threatening condition.

Who could benefit from this research

Good fit: Ideal candidates for this research are children aged 0-11 years who are diagnosed with sepsis and admitted to an intensive care unit.

Not a fit: Patients who are not diagnosed with sepsis or are outside the pediatric age range may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for children with sepsis, improving survival rates and outcomes.

How similar studies have performed: Previous research has shown promise in using personalized approaches to treat sepsis in adults, but this specific focus on pediatric patients is relatively novel.

Where this research is happening

PITTSBURGH, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: blood infection, bloodstream infection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.